Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 21 studies | 70% ± 18% | |
lung | 19 studies | 55% ± 13% | |
brain | 18 studies | 42% ± 19% | |
intestine | 12 studies | 42% ± 18% | |
kidney | 9 studies | 49% ± 21% | |
eye | 9 studies | 49% ± 19% | |
bone marrow | 7 studies | 40% ± 23% | |
lymph node | 6 studies | 70% ± 19% | |
liver | 6 studies | 50% ± 21% | |
placenta | 5 studies | 43% ± 14% | |
uterus | 5 studies | 54% ± 21% | |
prostate | 5 studies | 37% ± 9% | |
pancreas | 4 studies | 65% ± 25% | |
heart | 4 studies | 20% ± 6% | |
breast | 4 studies | 57% ± 9% | |
adipose | 3 studies | 35% ± 23% | |
adrenal gland | 3 studies | 57% ± 24% | |
esophagus | 3 studies | 41% ± 32% | |
thymus | 3 studies | 60% ± 24% | |
skin | 3 studies | 36% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 21939.11 | 2642 / 2642 | 100% | 563.79 | 705 / 705 |
pancreas | 100% | 12021.38 | 328 / 328 | 100% | 294.86 | 178 / 178 |
prostate | 100% | 12494.29 | 245 / 245 | 100% | 473.62 | 502 / 502 |
thymus | 100% | 13631.11 | 653 / 653 | 100% | 487.32 | 603 / 605 |
lung | 100% | 13734.05 | 578 / 578 | 100% | 224.34 | 1151 / 1155 |
adrenal gland | 100% | 24629.40 | 258 / 258 | 100% | 660.16 | 229 / 230 |
breast | 100% | 11838.06 | 459 / 459 | 99% | 347.65 | 1112 / 1118 |
esophagus | 100% | 7579.62 | 1444 / 1445 | 99% | 167.62 | 182 / 183 |
kidney | 100% | 10795.45 | 89 / 89 | 99% | 408.69 | 890 / 901 |
uterus | 100% | 12305.16 | 170 / 170 | 98% | 175.67 | 451 / 459 |
ovary | 100% | 18866.86 | 180 / 180 | 98% | 160.35 | 421 / 430 |
bladder | 100% | 10588.95 | 21 / 21 | 98% | 188.98 | 493 / 504 |
intestine | 100% | 10268.08 | 966 / 966 | 97% | 195.15 | 512 / 527 |
stomach | 100% | 9808.52 | 359 / 359 | 97% | 187.86 | 277 / 286 |
liver | 100% | 11653.89 | 226 / 226 | 97% | 179.31 | 392 / 406 |
skin | 100% | 7698.04 | 1803 / 1809 | 96% | 261.36 | 454 / 472 |
adipose | 100% | 11058.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 191.32 | 29 / 29 |
spleen | 100% | 11209.87 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 164.10 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 93.88 | 1 / 1 |
blood vessel | 100% | 12609.17 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 6436.43 | 793 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 8332.49 | 843 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 9600.50 | 892 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 174.40 | 74 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2001256 | Biological process | regulation of store-operated calcium entry |
GO_0006816 | Biological process | calcium ion transport |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0140268 | Cellular component | endoplasmic reticulum-plasma membrane contact site |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | SARAF |
Protein name | Store-operated calcium entry-associated regulatory factor (Transmembrane protein 66) Store-operated calcium entry-associated regulatory factor (SARAF) (SOCE-associated regulatory factor) (HBV X-transactivated gene 3 protein) (HBV XAg-transactivated protein 3) (Protein FOAP-7) (Transmembrane protein 66) Store-operated calcium entry associated regulatory factor |
Synonyms | UNQ1967/PRO4499 TMEM66 XTP3 HSPC035 PSEC0019 NPD003 |
Description | FUNCTION: Negative regulator of store-operated Ca(2+) entry (SOCE) involved in protecting cells from Ca(2+) overfilling. In response to cytosolic Ca(2+) elevation after endoplasmic reticulum Ca(2+) refilling, promotes a slow inactivation of STIM (STIM1 or STIM2)-dependent SOCE activity: possibly act by facilitating the deoligomerization of STIM to efficiently turn off ORAI when the endoplasmic reticulum lumen is filled with the appropriate Ca(2+) levels, and thus preventing the overload of the cell with excessive Ca(2+) ions. . FUNCTION: Negative regulator of store-operated Ca(2+) entry (SOCE) involved in protecting cells from Ca(2+) overfilling. In response to cytosolic Ca(2+) elevation after endoplasmic reticulum Ca(2+) refilling, promotes a slow inactivation of STIM (STIM1 or STIM2)-dependent SOCE activity: possibly act by facilitating the deoligomerization of STIM to efficiently turn off ORAI when the endoplasmic reticulum lumen is filled with the appropriate Ca(2+) levels, and thus preventing the overload of the cell with excessive Ca(2+) ions. . FUNCTION: Negative regulator of store-operated Ca(2+) entry (SOCE) involved in protecting cells from Ca(2+) overfilling. In response to cytosolic Ca(2+) elevation after endoplasmic reticulum Ca(2+) refilling, promotes a slow inactivation of STIM (STIM1 or STIM2)-dependent SOCE activity: possibly act by facilitating the deoligomerization of STIM to efficiently turn off ORAI when the endoplasmic reticulum lumen is filled with the appropriate Ca(2+) levels, and thus preventing the overload of the cell with excessive Ca(2+) ions. . FUNCTION: Negative regulator of store-operated Ca(2+) entry (SOCE) involved in protecting cells from Ca(2+) overfilling. In response to cytosolic Ca(2+) elevation after endoplasmic reticulum Ca(2+) refilling, promotes a slow inactivation of STIM (STIM1 or STIM2)-dependent SOCE activity: possibly act by facilitating the deoligomerization of STIM to efficiently turn off ORAI when the endoplasmic reticulum lumen is filled with the appropriate Ca(2+) levels, and thus preventing the overload of the cell with excessive Ca(2+) ions. . FUNCTION: Negative regulator of store-operated Ca(2+) entry (SOCE) involved in protecting cells from Ca(2+) overfilling. In response to cytosolic Ca(2+) elevation after endoplasmic reticulum Ca(2+) refilling, promotes a slow inactivation of STIM (STIM1 or STIM2)-dependent SOCE activity: possibly act by facilitating the deoligomerization of STIM to efficiently turn off ORAI when the endoplasmic reticulum lumen is filled with the appropriate Ca(2+) levels, and thus preventing the overload of the cell with excessive Ca(2+) ions. . FUNCTION: Negative regulator of store-operated Ca(2+) entry (SOCE) involved in protecting cells from Ca(2+) overfilling. In response to cytosolic Ca(2+) elevation after endoplasmic reticulum Ca(2+) refilling, promotes a slow inactivation of STIM (STIM1 or STIM2)-dependent SOCE activity: possibly act by facilitating the deoligomerization of STIM to efficiently turn off ORAI when the endoplasmic reticulum lumen is filled with the appropriate Ca(2+) levels, and thus preventing the overload of the cell with excessive Ca(2+) ions. . |
Accessions | Q96BY9 ENST00000520303.5 H0YAN9 ENST00000518174.5 ENST00000523761.1 ENST00000256255.11 [Q96BY9-1] ENST00000545648.2 [Q96BY9-2] ENST00000523127.5 H0YAZ1 E5RK07 H0YBH7 ENST00000518296.5 ENST00000522794.1 E5RJV6 ENST00000522055.1 E5RJG8 E5RHW0 E5RFJ9 ENST00000521265.5 ENST00000518340.1 |